Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HARMONY BIOSCIENCES HOLDINGS, INC.

(HRMY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Harmony Biosciences : Swings to Q2 Profit as Revenue Surges

08/10/2021 | 08:51am EST


ę MT Newswires 2021
All news about HARMONY BIOSCIENCES HOLDINGS, INC.
11/22HARMONY BIOSCIENCES : APPOINTS LINDA SZYPER TO ITS BOARD OF DIRECTORS - Form 8-K
PU
11/22HARMONY BIOSCIENCES HOLDINGS, INC. : Change in Directors or Principal Officers, Regulation..
AQ
11/22Harmony Biosciences Appoints Linda Szyper To Its Board Of Directors
PR
11/22Harmony Biosciences Holdings, Inc. Appoints Linda Szyper to Board of Directors
CI
11/18INSIDER SELL : Harmony Biosciences Holdings
MT
11/11Harmony Biosciences To Participate In Two Investor Conferences In November
PR
11/09Harmony Biosciences Reports Higher Q3 Earnings, Revenue
MT
11/09Q3 2021 Financial and Business Update
PU
11/09HARMONY BIOSCIENCES HOLDINGS, INC. Management's Discussion and Analysis of Financial C..
AQ
11/09HARMONY BIOSCIENCES REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND BUSINESS UPDATES -..
PU
More news
Analyst Recommendations on HARMONY BIOSCIENCES HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2021 306 M - -
Net income 2021 40,0 M - -
Net cash 2021 12,0 M - -
P/E ratio 2021 54,4x
Yield 2021 -
Capitalization 2 196 M 2 196 M -
EV / Sales 2021 7,14x
EV / Sales 2022 4,23x
Nbr of Employees 150
Free-Float 79,9%
Chart HARMONY BIOSCIENCES HOLDINGS, INC.
Duration : Period :
Harmony Biosciences Holdings, Inc. Technical Analysis Chart | HRMY | US4131971040 | MarketScreener
Technical analysis trends HARMONY BIOSCIENCES HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 37,55 $
Average target price 56,20 $
Spread / Average Target 49,7%
EPS Revisions
Managers and Directors
John C.s Jacobs President, Chief Executive Officer & Director
Sandipkumar S. Kapadia Chief Financial Officer
Jeffrey S. Aronin Non-Executive Chairman
Jeffrey M. Dayno Chief Medical Officer
David Bradshaw Head-Technical Operations
Sector and Competitors
1st jan.Capi. (M$)
HARMONY BIOSCIENCES HOLDINGS, INC.3.87%2 196
JOHNSON & JOHNSON1.16%419 109
ROCHE HOLDING AG16.05%336 162
PFIZER, INC.46.70%303 095
NOVO NORDISK A/S67.00%247 254
ELI LILLY AND COMPANY54.21%236 049